Blue Water Biotech, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1288041,
    "name": "Blue Water Biotech, Inc.",
    "stock_name": "Blue Water Biotech, Inc.",
    "full_name": "Blue Water Biotech, Inc.",
    "name_url": "stocks-analysis/blue-water-biotech-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.95",
    "chg": 0.46,
    "chgp": "18.47%",
    "dir": 1,
    "prev_price": "2.49",
    "mcapval": "1.61",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US09610B1089",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "8.86 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/blue-water-biotech-inc-1288041-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Blue Water Biotech, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-blue-water-biotech-inc-technically-bullish-or-bearish-3547912",
        "imagepath": "",
        "date": "2025-09-20 20:05:51",
        "description": "As of 17 July 2025, the technical trend for Blue Water Biotech, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages indicating a positive trend. However, the weekly MACD and KST are mildly bearish, suggesting some caution. The Bollinger Bands show a mixed signal with weekly mildly bullish and monthly mildly bearish readings. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past week and year, with a return of -4.15% compared to the S&P's 1.05% for the week, and -36.44% compared to the S&P's 17.14% for the year. Overall, while there are some bullish indicators, the mixed signals and recent performance suggest a cautious outlook...."
      },
      {
        "title": "Is Blue Water Biotech, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-blue-water-biotech-inc-overvalued-or-undervalued-3544127",
        "imagepath": "",
        "date": "2025-09-20 18:38:35",
        "description": "As of 29 August 2024, the valuation grade for Blue Water Biotech, Inc. has moved from does not qualify to risky, indicating increased concern regarding its financial health. The company appears to be overvalued given its significant losses and poor financial metrics, including a Price to Book Value of 0.11, an EV to EBIT of -1.72, and an EV to EBITDA of -1.89. \n\nIn comparison to peers, Blue Water Biotech's valuation ratios are concerning; for instance, Tonix Pharmaceuticals has an EV to EBITDA of -1.2007, while Cyclerion Therapeutics stands at -1.2082, both of which are better than Blue Water's metrics. The company's recent stock performance has been volatile, with a year-to-date return of 376.19%, significantly outperforming the S&P 500's 12.22%, but it has underperformed over the last year with a return of -36.44% compared to the S&P's 17.14%...."
      }
    ],
    "total": 6,
    "sid": "1288041",
    "stock_news_url": "https://www.marketsmojo.com/news/blue-water-biotech-inc-1288041"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Blue Water Biotech, Inc. technically bullish or bearish?

2025-09-20 20:05:51

As of 17 July 2025, the technical trend for Blue Water Biotech, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages indicating a positive trend. However, the weekly MACD and KST are mildly bearish, suggesting some caution. The Bollinger Bands show a mixed signal with weekly mildly bullish and monthly mildly bearish readings. In terms of performance, the stock has underperformed the S&P 500 over the past week and year, with a return of -4.15% compared to the S&P's 1.05% for the week, and -36.44% compared to the S&P's 17.14% for the year. Overall, while there are some bullish indicators, the mixed signals and recent performance suggest a cautious outlook....

Is Blue Water Biotech, Inc. overvalued or undervalued?

2025-09-20 18:38:35

As of 29 August 2024, the valuation grade for Blue Water Biotech, Inc. has moved from does not qualify to risky, indicating increased concern regarding its financial health. The company appears to be overvalued given its significant losses and poor financial metrics, including a Price to Book Value of 0.11, an EV to EBIT of -1.72, and an EV to EBITDA of -1.89. In comparison to peers, Blue Water Biotech's valuation ratios are concerning; for instance, Tonix Pharmaceuticals has an EV to EBITDA of -1.2007, while Cyclerion Therapeutics stands at -1.2082, both of which are better than Blue Water's metrics. The company's recent stock performance has been volatile, with a year-to-date return of 376.19%, significantly outperforming the S&P 500's 12.22%, but it has underperformed over the last year with a return of -36.44% compared to the S&P's 17.14%....

View All News